SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Hikal - Quaterly Results

09 May 2024 Evaluate
The sales for the March 2024 quarter moved down to Rs. 5141.00 millions as compared to Rs. 5452.90 millions during the year-ago period.A slender decline of -6.13% was recorded to Rs. 338.60  millions from Rs. 360.70 millions in the corresponding previous quarter.OP of the company witnessed a marginal growth to 948.10 millions from 884.60 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 5141.00 5452.90 -5.72 17846.00 20230.30 -11.79 17846.00 20230.30 -11.79
Other Income 4.60 3.80 21.05 24.50 54.10 -54.71 24.50 54.10 -54.71
PBIDT 948.10 884.60 7.18 2693.90 2624.70 2.64 2693.90 2624.70 2.64
Interest 152.60 129.80 17.57 563.70 481.00 17.19 563.70 481.00 17.19
PBDT 795.50 754.80 5.39 2130.20 2143.70 -0.63 2130.20 2143.70 -0.63
Depreciation 323.40 268.30 20.54 1176.10 1090.10 7.89 1176.10 1090.10 7.89
PBT 472.10 486.50 -2.96 954.10 1053.60 -9.44 954.10 1053.60 -9.44
TAX 133.50 125.80 6.12 259.00 269.80 -4.00 259.00 269.80 -4.00
Deferred Tax -26.40 -21.20 24.53 -24.70 -35.00 -29.43 -24.70 -35.00 -29.43
PAT 338.60 360.70 -6.13 695.10 783.80 -11.32 695.10 783.80 -11.32
Equity 246.60 246.60 0.00 246.60 246.60 0.00 246.60 246.60 0.00
PBIDTM(%) 18.44 16.22 13.68 15.10 12.97 16.35 15.10 12.97 16.35

Hikal Share Price

192.15 3.60 (1.91%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×